Oh I'm in agreement with you on this. Its tough tho for those that live with vulnerable folks and have to work and care for them.
Positive *Informative* Covid News
- Thread starter madguy30
- Start date
- Status
Oh I'm in agreement with you on this. Its tough tho for those that live with vulnerable folks and have to work and care for them.
Haha, I don't really care.
I just started the thread....I don't know own it, but sure. Start that up here. My guess it will be gone by...Friday? There's so much **** going on in the world right now that a grounded conversation actually sounds extreme so they rarely last.
I didn't really see it as a 'Sunshine, rainbows and unicorns' type of deal...just kind of working through the process of potential outcomes.
BTW, I wasn't asking you to do anything. I like positive news. Turn on the TV or read Twitter if you want constant negative news or fear.
This thread is definitely the violin players on the Titanic given the astoundingly embarrassing and tragic reality of the news today.
So, so need to have positive informative news or just positive or informative news. Man, this change is just stressing me out.....
I never did see this reconciled. One county.
That's interesting, in this one county 6.1% of the hospitalizations are between the ages of 10-19. Austin, TX nonetheless.
Teen COVID-19 hospitalizations on the rise in Travis County
Tuesday, Dr. Mark Escott with Austin Pubic Health said COVID-19 hospitalizations among patients 10-19 years old are at an all time high since the beginning of the pandemic. Currently, the 10-19 age group makes up 6. 1 percent of hospitalizations in the area and positivity rates among teens are...cbsaustin.com
I don't know what you mean by "reconciled"? That article doesn't share any data, just one doctor saying 6.1 ( is that a lot?) percent of their current hospitalizations are in that age group. It doesn't say if they are in and out quickly, how severely I'll they are, etc. It's also one county, so if I'm looking for a trend, I tend to believe the reports of 29 universities spread around the country is more indicative of the risk for college aged people than what one county is seeing.
I mean it's a chart made by a jihadist.
It's also the county Austin Texas is in, Baylor med, University of Texas. Sorry you missed that.
kcbob79clone
Well-Known Member
Per coronavirustoday.com
NSAIDs Do Not Lead to More Severe Coronavirus Disease Outcomes
The use of non-steroidal, anti-inflammatory drugs (NSAIDs) such as ibuprofen, is not associated with severe COVID-19 disease or related fatality, according to a study published in PLOS One on September 8, 2020.
These researchers concluded the 'use of NSAIDs was not associated with 30-day mortality, hospitalization, ICU admission, mechanical ventilation, or renal replacement therapy in Danish individuals who tested positive for the SARS-CoV-2 coronavirus.'
NSAIDs Do Not Lead to More Severe Coronavirus Disease Outcomes
The use of non-steroidal, anti-inflammatory drugs (NSAIDs) such as ibuprofen, is not associated with severe COVID-19 disease or related fatality, according to a study published in PLOS One on September 8, 2020.
These researchers concluded the 'use of NSAIDs was not associated with 30-day mortality, hospitalization, ICU admission, mechanical ventilation, or renal replacement therapy in Danish individuals who tested positive for the SARS-CoV-2 coronavirus.'
kcbob79clone
Well-Known Member
Also per coronavirustoday.com. Heard about the double test before
Triple Test Launched to Detect COVID-19, Influenza, and RSV
North Carolina based LabCorp announced on September 8, 2020, the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (RSV). This single-panel test, which detects multiple types of infections, can help doctors diagnose patients and make decisions about treatment options.
The combination diagnostic test is available to patients through doctors, hospitals, and other authorized healthcare providers nationwide.
Triple Test Launched to Detect COVID-19, Influenza, and RSV
North Carolina based LabCorp announced on September 8, 2020, the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (RSV). This single-panel test, which detects multiple types of infections, can help doctors diagnose patients and make decisions about treatment options.
The combination diagnostic test is available to patients through doctors, hospitals, and other authorized healthcare providers nationwide.
kcbob79clone
Well-Known Member
Also per coronavirustoday.com. Amazing what has happened in a few short months
243 Coronavirus Disease-Related Diagnostic Tests Now Authorized
As of September 8, 2020, the U.S. FDA had authorized 243 coronavirus disease-related diagnostic tests, which include 195 molecular tests, 44 antibody tests, and 4 antigen tests.
The two most common types of tests people discuss are RT-PCR, the nasal-swab test that detects viral RNA, and various antibody tests, that detect if you have an immune response due to past exposure to the SARS-CoV-2 virus, says the FDA.
243 Coronavirus Disease-Related Diagnostic Tests Now Authorized
As of September 8, 2020, the U.S. FDA had authorized 243 coronavirus disease-related diagnostic tests, which include 195 molecular tests, 44 antibody tests, and 4 antigen tests.
The two most common types of tests people discuss are RT-PCR, the nasal-swab test that detects viral RNA, and various antibody tests, that detect if you have an immune response due to past exposure to the SARS-CoV-2 virus, says the FDA.
kcbob79clone
Well-Known Member
Also per coronavirustoday.com
Orally-Administered Antiviral Candidate 'Inhibited' COVID-19
Israel based RedHill Biopharma Ltd. announced on September 8, 2020, that opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral replication in an in vitro model of human lung bronchial tissue. Opaganib is currently being evaluated in global Phase 2/3 and U.S. Phase 2 clinical studies for the treatment of severe COVID-19 pneumonia.
Results from this study 'showed a clear and compelling antiviral effect of opaganib against SARS-CoV-2,' stated the company's press statement.
Mark L. Levitt, M.D., Ph.D., Medical Director at RedHill, added: “We are accelerating progress toward our goal of generating a robust data package to potentially support emergency use authorizations for COVID-19.”
Opaganib is a first-in-class, orally-administered, sphingosine kinase-2 (SK2) selective inhibitor with dual anti-inflammatory and anti-viral activity that targets a host cell component, unaffected by viral mutation, thus minimizing the likelihood of resistance, says the company.
Orally-Administered Antiviral Candidate 'Inhibited' COVID-19
Israel based RedHill Biopharma Ltd. announced on September 8, 2020, that opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral replication in an in vitro model of human lung bronchial tissue. Opaganib is currently being evaluated in global Phase 2/3 and U.S. Phase 2 clinical studies for the treatment of severe COVID-19 pneumonia.
Results from this study 'showed a clear and compelling antiviral effect of opaganib against SARS-CoV-2,' stated the company's press statement.
Mark L. Levitt, M.D., Ph.D., Medical Director at RedHill, added: “We are accelerating progress toward our goal of generating a robust data package to potentially support emergency use authorizations for COVID-19.”
Opaganib is a first-in-class, orally-administered, sphingosine kinase-2 (SK2) selective inhibitor with dual anti-inflammatory and anti-viral activity that targets a host cell component, unaffected by viral mutation, thus minimizing the likelihood of resistance, says the company.
kcbob79clone
Well-Known Member
Also per coronavirustoday.com. I didn't know there were so many vaccine candidates for a virus that has only been around a few months.
33 Coronavirus Vaccine Candidates Currently Conducting Research
As of September 3, 2020, the global COVID-19 vaccine R&D landscape included 321 vaccine candidates. Of these, 33 vaccine candidates are in clinical trials, with plans to enroll more than 280,000 participants from at least 470 sites in 34 different countries, reported Nature. Highlighted phase 3 coronavirus preventive vaccine candidates can be found at this link.
There are 381 clinical studies in the USA currently recruiting participants listed in the Antidote database, as of September 8, 2020.
33 Coronavirus Vaccine Candidates Currently Conducting Research
As of September 3, 2020, the global COVID-19 vaccine R&D landscape included 321 vaccine candidates. Of these, 33 vaccine candidates are in clinical trials, with plans to enroll more than 280,000 participants from at least 470 sites in 34 different countries, reported Nature. Highlighted phase 3 coronavirus preventive vaccine candidates can be found at this link.
There are 381 clinical studies in the USA currently recruiting participants listed in the Antidote database, as of September 8, 2020.
Welcome to Precision Vaccinations News
Precision Vaccinations News publishes vaccine news patients can trust to make informed immunization decisions in partnership with doctors, nurses, and pharmacists.
People can subscribe to save you the time of spamming everything to this thread.
kcbob79clone
Well-Known Member
Welcome to Precision Vaccinations News
Precision Vaccinations News publishes vaccine news patients can trust to make informed immunization decisions in partnership with doctors, nurses, and pharmacists.www.coronavirustoday.com
People can subscribe to save you the time of spamming everything to this thread.
Appreciate the sentiment friend but I am retired and I have the time, especially when it is positive informative news.
- Status
